Loading Events

« All Events

  • This event has passed.

Financing of the G-Stat MIRCADE project by SATT Aquitaine

21 March

SATT Aquitaine invests in the maturation of innovative projects from regional public research. SATT Aquitaine’s objective is to mature these inventions, from the stage of research results to pre-industrialization (proof of concept), and to support them until they are brought to market.

Lead by Christophe Grosset, Inserm research director and head of theTeam 06 – MIRCADE, Methods and Innovations for the Research in Pediatric Cancers., the GSTAT project offers a new therapeutic option for the treatment of an incurable solid tumor in children, the infiltrating glioma of the brain stem.
The objective of SATT Aquitaine’s €641,000 investment is to formulate and test the drug candidate in-vitro and in-vivo using the molecules identified during the research team’s work.

More information at this link


21 March
Event Category: